Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Emory University
M.D. Anderson Cancer Center
Innovent Biologics (Suzhou) Co. Ltd.
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
University of Chicago
M.D. Anderson Cancer Center
NYU Langone Health